Abiopharma

🔍 DUKEMAN VAN A (Director)

Company: FIRST BUSEY CORP /NV/ (BUSE)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 1,046 shares of Common Stock at $20.315 per share (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 460,124.83 | transaction_form_type: 5 | Footnotes: F1
• Acquired 1,128 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 461,252.83 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: H | nature_of_ownership: 401(k) & Profit Sharing Plan | shares_owned_after: 14,034.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: H | nature_of_ownership: Spouse IRA | shares_owned_after: 2,201.00

Footnotes:

• F1: Shares were acquired under the First Busey Corporation Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(c) and Rule 16b-3(d).
• F2: Represents dividend equivalent rights accrued on Restricted Stock Units in connection with the payment of a cash dividend on First Busey Corporation Common Stock. Each dividend equivalent right is the economic equivalent of one share of First Busey Corporation Common Stock.